Fig. 4From: Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor TherapyThe effect of treatment with C60 fullerene, Dox, and C60 + Dox complex on the cytotoxic activity of mononuclear splenic leukocytes towards autologic tumor cells in LLC-bearing mice; *the differences are statistically valid compared to the control and intact animals (t test; p < 0.05)Back to article page